The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: A randomized clinical trial

Interactive Cardiovascular and Thoracic Surgery

Volumn 15, Issue 6, 2012, Pages 1013-1018

  Garrido Martín, Pilar ^a   Nassar Mansur, Mohamed Ibrahim ^a   De La Llana Ducrós, Ramiro ^a   Virgos Aller, Tirso Mordf ^a   Fortunez, Patricia María Rodríguez ^a   Ávalos Pinto, Rosa ^a   Jimenez Sosa, Alejandro ^a   Martínez Sanz, Rafael ^a,b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Anaemia; Cardiac surgery; Ineffective treatments; Intravenous iron supplement; Transfusions

Indexed keywords

FERRITIN; FERROUS FUMARATE; HEMOGLOBIN; IRON SACCHARATE; PLACEBO;

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPERATING ROOM; PARALLEL DESIGN; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; ANEMIA, IRON-DEFICIENCY; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SPAIN; SUCROSE; SURGICAL PROCEDURES, ELECTIVE; TABLETS; TIME FACTORS; TREATMENT FAILURE;

EID: 84870184808     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs344     Document Type: Article

References (31)

1. Butler J, Rocker G, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9. (Pubitemid 23060844)
2. Huyzen RJ, van Oeveren W, Wei F, Stellingwerf P, Boonstra PW, Gu YJ. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass. Ann Thorac Surg 1996; 62:533-7. (Pubitemid 26259700)
3. Boyle E, Verrier E, Spiess B. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg 1996;62:549-1557.
4. Leal Noval S, Rincon-Ferrari MD, Garcia Curiel A, Herruzo Avilés A, Camacho Laraña P, Garnacho Montero J et al. Transfusión of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-8. (Pubitemid 32686030)
5. Reddy SM, Talwar S, Velayoudam D, Parag Charde P, Mallick V, Jha RJ et al. Multi-modality blood conservation strategy in open-heart surgery: an audit. Interact CardioVasc Thorac Surg 2009;9:480-3.
6. Goldberg M. Erythropoieis, erythropoietin and iron metabolism in elective surgery: preoperative strategies for avoiding allogenic blood exposure. Am J Surg 1995;170:S37-43.
7. Silverberg DS, Laina A, Peer G, Kaplan E, Levi BA, Frank N et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients nor receiving dialysis. Am J Kidney Dis 1996;27:234-8. (Pubitemid 26055136)
8. Rohling RG, Zimmerman AP, Breymann C. Intravenous versus oral iron supplementation for preoperative stimulation of haemoglobin synthesis using recombinant human erythropoietin. J Hematother Stem Cell Res 2000;9:497-500.
9. Schaefer RM, Schaefer L. Iron monitoring and supplementation: how do we achieve the best results? Nephrol Dial Transplant 1998;13:9-12. (Pubitemid 28154287)
10. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl 1999;69:S61-6.
11. Beris P. Perisurgical intravenous iron therapy. Transfusion alternatives. Transfus Med 1999;4:35-8.
12. Berniere J, Dehullu JP. Le fer intraveineux dans le traitement des anèmies postoperatoires dans la chirurgie du rachis de l'enfant et de l'adolescent. Rev Chir Orthoped 1998;84:319-22. (Pubitemid 28313311)
13. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder Ramos SA et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007;116:471-9.
14. Beris P, Muñoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008;100:599-604. (Pubitemid 351774360)
15. Gupta A. Pathogenesis of anaphylactoid reactions to intravenous iron. Am J Kidney Dis 2000;35:360-3.
16. Beris P, Muñoz M, García Erce JA, Thomas D, Maniatis A, Linden V. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008;100:599-604. (Pubitemid 351774360)
17. Madi-Jebara SN, Sleilaty GS, Achouh PE, Yazigi AG, Haddad FA, Hayek GM et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004;18:59-63. (Pubitemid 38240762)
18. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006;53:11-9. (Pubitemid 43230987)
19. Crosby L, Palarski VA, Cotington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart Lung 1994;23:493-9. (Pubitemid 24378723)
20. Sowade O, Messinger D, Franke W, Sowade B, Scigalla P, Warnke H. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery. Eur J Haematol 1998;60:252-9. (Pubitemid 28179407)
21. Muñoz M, Leal-Noval R. Intravenous iron in cardiac surgery. Semin Hematol 2006;43(Suppl. 6):46-9.
22. Bolger AP, Bartlett FR, Penstons HS, O'Leary J, Pollock N, Kaprielian R et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:225-7.
23. Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM. Intravenous iron following cardiac surgery does not increase the infection rate. Surg Infect 2006;7:61-6.
24. Ahsan N. Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: a single center comparative study. J Am Soc Nephrol 1998;9:664-8.
25. Huli S, Durandy Y. Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy. Ann Fr Anesth Reanim 2005;24:1262-5. (Pubitemid 41463411)
26. Garrido-Martin P, Nassar-Mansur M, Ramiro de la Llana-Ducros et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact CardioVasc Thorac Surg 2012;15:1013-18.
27. Munoz M, Breymann C, Garcia-Erce JA, Gomez-Ramirez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sanguinis 2008;94:172-183. (Pubitemid 351379653)
28. Moore RA, Gaskell H, Rose P, Allan J. Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. BMC Blood Disord 2011;24:4.
29. Bockeria L, Bockeria O, Mota O, Rahimov A, Donakanian S. Bleeding in cardiac surgery practice: diagnostics and treatment. Bulletin of Bakoulev CCVS RAMS for Cardiovascular Surgery 2009;10:39-49.
30. Garrido-Martin P, Nassar-Mansur M, Ramiro de la Llana-Ducros et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact CardioVasc Thorac Surg 2012; 15:1013-18.
31. Leal-Noval SR, Rincón-Ferrari MD, García-Curiel A, Herruzo-Avilés A, Camacho-Laraña P, Garnacho-Montero J et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-8 (Pubitemid 32686030)